Journal of Gastroenterology

, Volume 32, Issue 3, pp 318–323 | Cite as

Red cell survival in patients with nonalcoholic liver cirrhosis before and after distal splenorenal shunt

  • Manabu Nishiwaki
  • Hiroshi Ashida
  • Akihiko Nishioka
  • Joji Utsunomiya
Liver, Pancreas, and Biliary Tract


We previously reported severe hemolysis in one patient immediately after distal splenorenal shunt (DSRS). The purpose of the present study was to evaluate changes in red cell survival after DSRS. In ten patients with nonalcoholic cirrhosis in whom DSRS was performed for esophageal varices, red cell survival and splenic quantitative hemodynamic studies were performed before and after DSRS. The splenic venous blood flow per unit volume (flow/volume ratio) was calculated. The red cell survival was significantly (P<0.05) shortened after DSRS; the apparent half-life survival time (T1/2) before and after DSRS was 24.6±5.9 (mean±SD) and 16.3±8.5 days, respectively. After DSRS, the spleen volume was significantly (P<0.05) decreased, whereas the splenic venous blood flow was slightly increased. The spleen flow/volume ratio was significantly (P<0.05) increased after DSRS. There was a significant and negative correlation (r=−0.684,P<0.05) between the postoperative percentage change in T1/2 and the spleen flow/volume ratio. These findings suggest that the red cell survival period is significantly decreased after DSRS in patients with nonalcoholic cirrhosis, and that the increased splenic blood flow per unit spleen volume after DSRS may play an important role in the hemolytic reaction in the spleen after this procedure.

Key words

distal splenorenal shunt red cell survival hemolysis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Warren WD, Zeppa R, Fomon JJ. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967;166:437–455.PubMedCrossRefGoogle Scholar
  2. 2.
    Eichner ER. Splenic function: Normal, too much and too little. Am J Med 1979;66:311–320.PubMedCrossRefGoogle Scholar
  3. 3.
    Ashida H, Kotoura Y, Takagi K, et al. Severe hemolysis after distal splenorenal shunt. Am J Gastroenterol 1989;84:71–74.PubMedGoogle Scholar
  4. 4.
    Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646–649.PubMedCrossRefGoogle Scholar
  5. 5.
    Warren WD, Millikan WJ, Henderson JM, et al. Selective variceal decompression after splenectomy or splenic vein thrombosis. With a note on splenopancreatic disconnection. Ann Surg 1984;6:694–702.CrossRefGoogle Scholar
  6. 6.
    Ashida H, Utsunomiya J, Kotoura Y, et al. Results of distal splenorenal shunt with versus without splenopancreatic disconnection. J Clin Gastroenterol 1989;11:658–662.PubMedCrossRefGoogle Scholar
  7. 7.
    Mollison PL, Veall H. Use of the isotope51Cr as label for red cells. Br J Haematol 1955;1:62–74.PubMedCrossRefGoogle Scholar
  8. 8.
    Goldberg A, Hutchison HE, MacDonald E. Radiochromium in the selection of patients with haemolytic anaemia for splenectomy. Lancet 1966;I:109–114.CrossRefGoogle Scholar
  9. 9.
    Takagi K, Ashida H, Utsunomiya J. The effect of splenomegaly on splanchnic hemodynamics in nonalcoholic cirrhosis after distal splenorenal shunt and splenopancreatic disconnection. Hepatology 1994;20:342–348.PubMedCrossRefGoogle Scholar
  10. 10.
    Subhiyah BW, Al-Hindawi AY. Red cell survival and splenic accumulation of radio chromium in liver cirrhosis with splenomegaly. Br J Haematol 1967;13:773–778.PubMedCrossRefGoogle Scholar
  11. 11.
    Chaplin H Jr, Mollison PL. Red cell life-span in nephritis and hepatic cirrhosis. Clin Sci 1953;12:351–360.PubMedGoogle Scholar
  12. 12.
    Allen FA, Carr MH, Klotz AP. Decreased red blood cell-survival time in patients with portal cirrhosis. Correlation of laboratory and clinical findings. J Am Med Assoc 1957;164:955–959.PubMedGoogle Scholar
  13. 13.
    Jandl JH, Simmons RL, Castle WB. Red cell filtration and pathogenesis of certain hemolytic anemias. Blood 1961;18:133–148.PubMedGoogle Scholar
  14. 14.
    Holzbach RT, Shipley RA, Clark SR, et al. Influence of spleen size and portal pressure on erythrocyte sequestration. J Clin Invest 1964;43:1125–1135.PubMedCrossRefGoogle Scholar
  15. 15.
    Hutson DG, Zeppa R, Levi JU, et al. The effect of the distal splenorenal shunt on hypersplenism. Ann Surg 1977;185:605–610.PubMedCrossRefGoogle Scholar
  16. 16.
    Marni A, Trojsi C, Belli L. Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status. Hepatic function and hypersplenism. Am J Surg 1981;142:372–376.PubMedCrossRefGoogle Scholar
  17. 17.
    Ferrara J, Ellison C, Martin EW, et al. Correction of hypersplenism following distal splenorenal shunt. Surg 1979; 86:570–573.Google Scholar
  18. 18.
    Ashida H, Takagi K, Nishioka A, et al. Hemodynamic changes in splenic blood flow during and after distal splenorenal shunt. Am J Gastroenterol 1990;85:1609–1613.PubMedGoogle Scholar
  19. 19.
    El-Khishen MA, Henderson JM, Millikan WJ, et al. Splenectomy is contraindicated for thrombocytopenia secondary to portal hypertension. Surg Gynecol Obstet 1985;160:233–238.PubMedGoogle Scholar
  20. 20.
    Da Silva LC, Jamra MA, Maspes V, et al. Pathogenesis of indirect reacting hyperbilirubinemia after portacaval anastomosis. Gastroenterology 1963;44:117–124.PubMedGoogle Scholar
  21. 21.
    Redetzki JE, Bickers JN, Samuels M, et al. Progressive hypersplenism after portacaval anastomosis. Report of three cases. Am J Dig Dis 1967;12:88–97.PubMedCrossRefGoogle Scholar
  22. 22.
    Ezzat FA, Abu-Elmagd KM, Aly IY, et al. Distal splenorenal shunt for management of variceal bleeding in patients with schistosomal hepatic fibrosis. Ann Surg 1986;204:566–574.PubMedCrossRefGoogle Scholar
  23. 23.
    Ezzat FA, Abu-Elmagd KM, Sultan AA, et al. Schistosomal versus nonschistosomal variceal bleeders. Do they respond differently to selective shunt (DSRS)? Ann Surg 1989;209:489–500.PubMedCrossRefGoogle Scholar
  24. 24.
    Maillard JN, Flamant YM, Hay JM, et al. Selectivity of the distal splenorenal shunt. Surgery 1979;166:663–671.Google Scholar
  25. 25.
    Cooper RA, Diloy-Puray M, Lando P, et al. An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease. J Clin Invest 1972;51:3182–3192.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • Manabu Nishiwaki
    • 1
  • Hiroshi Ashida
    • 1
  • Akihiko Nishioka
    • 1
  • Joji Utsunomiya
    • 1
  1. 1.Second Department of SurgeryHyogo College of MedicineNishinomiyaJapan

Personalised recommendations